Full Vs Partial Weightbearing During the First Six Weeks of Rehab. After Fibular Collateral Ligament Reconstruction
Launched by TWIN CITIES ORTHOPEDICS · Sep 28, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how much weight patients can safely put on their knee after surgery to repair a ligament in the knee, known as the fibular collateral ligament (FCL). The goal is to see whether starting to put full weight on the knee right after surgery is safe, compared to putting only a little weight on it for the first six weeks. This research is important for helping patients recover from knee injuries and understanding the best way to support their healing.
To be eligible for this trial, participants must be between 14 and 60 years old and have had surgery to repair the FCL, either alone or along with another ligament called the anterior cruciate ligament (ACL). Both men and women can join if they are able to follow the study guidelines and understand the consent form. Participants will be monitored during their recovery, and they’ll follow specific instructions about how much weight to put on their knee during the first six weeks after surgery. This study is currently looking for volunteers, and it aims to provide valuable insights into the best practices for rehabilitation after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 14 years old, \<60
- • Reconstruction of FCL alone
- • Combined FCL + ACL reconstructions
- • Males or females
- • Is willing and able to comply with the clinical trial plan and able to understand and sign the Patient Informed Consent Form.
- Exclusion Criteria:
- • \< 14 years old, \> 60
- • Pregnant
- • Revision FCL reconstructions
- • Concurrent biceps femoris or lateral capsular repairs
- • Concurrent PCL or MCL reconstructions
- • Concomitant meniscus root or radial repair surgery with transtibial technique
About Twin Cities Orthopedics
Twin Cities Orthopedics (TCO) is a leading orthopedic practice dedicated to providing innovative and comprehensive musculoskeletal care. With a commitment to advancing medical research and improving patient outcomes, TCO conducts clinical trials that explore cutting-edge treatments and technologies in orthopedics. The organization collaborates with a diverse team of specialists, leveraging their expertise to enhance the understanding of orthopedic conditions and develop evidence-based solutions. TCO's focus on patient-centered care, combined with its robust research initiatives, positions it as a pivotal contributor to the advancement of orthopedic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edina, Minnesota, United States
Patients applied
Trial Officials
Robert F LaPrade, MD, PhD
Principal Investigator
Twin Cities Orthopedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials